Russell Mumper

Research programs are focused primarily in five areas including;

1) nanotemplate engineering of nano-based detection devices and cell-specific nanoparticles for tumor and dendritic cell targeting and vaccines, 2) biocompatibility, hemocompatibility, and toxicology of nanoparticles and nanomaterials, 3) drug-polymer conjugates,  4) mucoadhesive gels and thin-films for (trans)mucosal delivery of drugs, vaccines, and microbicides, and 5) anticancer and anti-inflammatory properties of berries and berry extracts.

2012  Harvard Macy Scholar, Harvard Macy Institute’s 2012 Program for Leading Innovations in Healthcare and Education

2012  Acceptance of project titled “Oil-filled Nanocapsules Containing a Docetaxel Lipid-Conjugate for Treatment of Non-Small Cell Lung Cancer” into the Nanotechnology Characterization Lab’s Advanced Technology Program at the National Cancer Institute.  This was the first nanotechnology-based cancer technology/product developed at UNC to be accepted into the Program    

2012   PY1 Instructor of the Year, UNC Eshelman School of Pharmacy

2012   Advisory Scientific Panel. The Fourth International Conference on Modern Vaccines Adjuvants & Delivery Systems.  Eigtveds Pakhus. Copenhagen, Denmark.  July 4-6, 2012

2010 – pres.  Chair, Bio-Targeting Working Group, NCI Alliance for Nanotechnology in Cancer

2009 – pres.  Steering Committee Member, AAPS Nanotechnology Focus Group

2009  Elected Fellow, American Association of Pharmaceutical Scientists (AAPS)

2007 Great Teacher Award. The UK Alumni Association Great Teacher Award recognizes annually six outstanding faculty members at UK for their work in the classroom. It is the oldest, continuously given award for teaching on the UK campus. Since its inception in 1961, 223 faculty members have been honored with this prestigious award.